| Model Number |
AB9U16060090 |
| Medical Device Problem Code |
Premature Activation (1484)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
04/14/2021
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
It was reported that a physician was attempting to use a abre self-expanding stent device to treat a lesion in the left distal common iliac vein in a patient.Ifu was followed with no issues noted.It was reported that deployment difficulties occurred ¿ the physician deployed stent partially with intent to reposition.Upon attempting to reposition, stent locked into place in vessel and as physician pulled back, stent was deployed in vessel without using thumbwheel to release stent.Thumbscrew/lock-pin was checked for securement prior to procedure.The lock-pin removed prior to stent delivery.The lesion was not predilated, did not pass through a previously deployed stent.No resistance was encountered, and no excessive force was used.The procedure was completed by pulling back the delivery catheter and the stent came out of device into vessel without using thumbwheel for delivery.No patient injury reported for this event.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Search Alerts/Recalls
|